Daiichi Electronic company information, Employees & Contact Information

Ifinatamab Deruxtecan Granted Breakthrough Therapy Designation by U.S. FDA for Patients with Pretreated Extensive-Stage Small Cell Lung Cancer Business Wire

At ASCO 2025, attendees see reason for hope, despite worries statnews.com

The First Small Steps: Debris Removal at Fukushima Daiichi nippon.com

Daiichi Sankyo, AstraZeneca Withdraw EU MAA for Dato-DXd in Advanced Nonsquamous NSCLC OncLive

Ono’s FDA Rare Cancer Approval Sets Up Face Off With Daiichi Sankyo BioSpace

AstraZeneca/Daiichi Sankyo survey reveals breast cancer misconceptions in Europe PMLiVE

'Nervous and rushed': Massive Fukushima plant cleanup work involves high radiation and stress AP News

Ifinatamab Deruxtecan Demonstrated Clinically Meaningful Response Rates in Patients with Extensive-Stage Small Cell Lung Cancer in IDeate-Lung01 Phase 2 Trial Business Wire

Fukushima Daiichi Workers Share Their Stories nippon.com

After failing to get Seagen Merck turns to Daiichi | ApexOnco - Clinical Trials news and analysis Oncology Pipeline

Wayfinder Biosciences and Daiichi Sankyo collaborate to develop novel RNA-targeting therapies for neurodegenerative disease PR Newswire

AstraZeneca and Daiichi Sankyo report data from Phase III breast cancer trial Clinical Trials Arena

Merck and Daiichi Sankyo’s I-DXd Earns FDA Breakthrough Therapy Status in Small Cell Lung Cancer BioPharm International

Daiichi Sankyo Appoints Hiroyuki Okuzawa as Chief Executive Officer Yahoo Finance

Fukushima disaster: What happened at the nuclear plant? BBC

Daiichi press release found to discredit pharma on safety grounds, prompting scolding from UK body Fierce Pharma

Particulate plutonium released from the Fukushima Daiichi meltdowns ScienceDirect.com

Aiming to become an Innovative Global Healthcare Company — What is the grand design of Daiichi Sankyo’s DX strategy? PwC

Daiichi invests 1 bln eur near Munich to make precision cancer drugs Reuters

Daiichi Sankyo and Merck Announce Global Development and Commercialization Collaboration for Three Daiichi Sankyo DXd ADCs Business Wire

AstraZeneca outlines AI-enabled TROP2 biomarker strategy for Daiichi ADC after limited lung cancer showing Fierce Biotech

Nexletol partners Esperion and Daiichi Sankyo patch up milestone dispute with $125M settlement Fierce Pharma

Daiichi Sankyo-Merck's 'guided-missile' cancer drug meets main goal in late-stage trial Reuters

Daiichi's lung cancer ADC rejected by FDA in blow to first project under Merck partnership Fierce Pharma

Merck’s ADC Pact With Daiichi Hits Regulatory Setback in FDA Rejection BioSpace

Datroway, 2nd ADC from AstraZeneca-Daiichi collab, wins first FDA nod in breast cancer Fierce Pharma

Without Pfizer appeal, Daiichi Sankyo closes long-running ADC patent arbitration with $47M win Fierce Pharma

Esperion and Daiichi Sankyo Europe Announce $125 Million Amendment to Their Collaboration, Including Resolution of Pending Litigation Business Wire

At Fukushima Daiichi, decommissioning the nuclear plant is far more challenging than water release AP News

Merck expands ADC partnership with Daiichi Sankyo in a $170m deal BioProcess International

Kite and Daiichi Sankyo Announce Changes to YESCARTA® CAR T-Cell Therapy Licensing Agreement in Japan Business Wire

Visualization of radiocesium distribution in surface layer of seafloor around Fukushima Daiichi Nuclear Power Plant Nature

After FDA snub, Daiichi's Vanflyta gains US approval and tees up AML clash with Novartis, Astellas Fierce Pharma

US agency nixes Seagen patent, handing Daiichi Sankyo a win in long-running Enhertu entanglement Fierce Pharma

Daiichi Sankyo’s Quizartinib Trial: A New Hope for AML Treatment? TipRanks

Daiichi Sankyo’s valemetostat fares well in lymphoma and leukemia study drugdiscoverytrends.com

Immuto Scientific Announces $8M Seed 2 Financing and Daiichi Sankyo Collaboration to Uncover a New Class of Therapeutic Targets with Structural Surfaceomics Business Wire

Daiichi Sankyo, Inc. Launches CommitmentsinPainCare.com PR Newswire

Daiichi Sankyo and Merck Enter into Global Development and Commercialization Agreement for MK-6070 Business Wire

Daiichi Sankyo Again Raises Enhertu Sales Forecast Driven by Non-US Growth BioSpace

Eyes on Asia: Eisai’s EU win, Daiichi, Haleon BioXconomy

AstraZeneca and Daiichi Sankyo’s Enhertu receives EU approval PharmaTimes

Conditions inside Fukushima's melted nuclear reactors still unclear 13 years after disaster struck AP News

Depixus Announces Strategic Collaboration With Daiichi Sankyo to Use MAGNA™ Technology to Accelerate RNA-targeted Drug Discovery Business Wire

Daiichi Sankyo’s Promising Gastrointestinal Cancer Study: A Market Game-Changer? TipRanks

Small head size and delayed body weight growth in wild Japanese monkey fetuses after the Fukushima Daiichi nuclear disaster Nature

AstraZeneca, Daiichi announce results from DESTINY-Breast11 Phase III trial TipRanks

Caesium-rich micro-particles: A window into the meltdown events at the Fukushima Daiichi Nuclear Power Plant Nature

AstraZeneca, Daiichi announce ENHERTU showed improvement in IDFS TipRanks

AstraZeneca, Daiichi Sankyo Enhertu plus pertuzumab sBLA granted priority review TipRanks

Fukushima Daiichi nuclear plant starts 3rd release of treated radioactive wastewater into the sea AP News

Daiichi Sankyo, Inc. Adds to Its Dynamic Team, Welcoming Leigh Ann Errico as the New Vice President of Human Resources for the U.S. Commercial Group PR Newswire

Morphological defects in native Japanese fir trees around the Fukushima Daiichi Nuclear Power Plant Nature

China bans seafood from Japan after the Fukushima nuclear plant begins its wastewater release AP News

Fukushima Daiichi: Progress to Date and the Challenges that Remain nippon.com

Initial flux of sediment-associated radiocesium to the ocean from the largest river impacted by Fukushima Daiichi Nuclear Power Plant Nature

Fukushima Daiichi Releases Nearly 55,000 Cubic Meters of Treated Wastewater in First Year nippon.com

Recording the Past and Communicating the Present: Fukushima Daiichi’s Archive Center nippon.com

Patritumab Deruxtecan Demonstrated Statistically Significant Improvement in Progression-Free Survival Versus Doublet Chemotherapy in Patients with Locally Advanced or Metastatic EGFR-Mutated Non-Small Cell Lung Cancer in HERTHENA-Lung02 Phase Business Wire

Detection of alpha particle emitters originating from nuclear fuel inside reactor building of Fukushima Daiichi Nuclear Power Plant Nature

Daiichi Sankyo starts mirogabalin trial in spinal injury pain PMLiVE

Five years on, cleanup of Fukushima's reactors remains a distant goal The Guardian

Fukushima Daiichi Today: Successes and Setbacks nippon.com

Fukushima nuclear reactor radiation at highest level since 2011 meltdown The Guardian

Nationalize the Fukushima Daiichi atomic plant Nature

Japanese drugmaker Daiichi wins damages from former Ranbaxy owners Reuters

Daiichi Sankyo applies for approval of mRNA COVID vaccine 朝日新聞

Status of the Nuclear Reactors at the Fukushima Daiichi Power Plant - Interactive Graphic - NYTimes.com The New York Times

Effects of the Fukushima Daiichi Nuclear Disaster nippon.com

Japan’s $320 Million Gamble at Fukushima: An Underground Ice Wall (Published 2016) The New York Times

Leaks, Rats and Radioactivity: Fukushima’s Nuclear Cleanup Is Faltering | TIME.com Time Magazine

Daiichi Sankyo Sells Shares Of Sun Pharma Asian Scientist Magazine

Report Gives New Details of Chaos at Stricken Plant (Published 2011) The New York Times

Japan Faces Potential Nuclear Disaster as Radiation Levels Rise (Published 2011) The New York Times

Nuclear Safety Five Years after the Fukushima Daiichi Accident The Bahamas Weekly

Sun Pharma to acquire 11.28 pc stake in Zenotech from Daiichi Sankyo Business Standard

Five key takeaways from the Ranbaxy-Daiichi Dispute Bar and Bench

Daiichi Properties, CBRE partner for One World Place Philstar.com